|Slideshows|April 16, 2021

10 Meditations on a Virtuous Career

Beyond earning a medical degree, completing residency, and obtaining board certification and licensure, a psychiatrist's career grows to be illustrious with wisdom, curiosity, intellect, aesthetic sensitivity, compassion, empathy, generosity, and more.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Striking a Balance: What Consultation-Liaison Psychiatrists Should Know About the Hospital Psychological Milieu During a Strike

ByAdrienne D. Mishkin, MD, MPH, MS,Sara S. Nash, MD,Christina Kitt Garza, MD

March 11th 2026

On Mentoring

ByJohn J. Miller, MD

October 9th 2025

Spare Me the Bouquets: The Growing Crisis of Being a Doctor in India

ByHarneet Kaur, MD

July 1st 2025

Walking the Line: Navigating Student Mistreatment by Patients

ByMadeline Hawkins,Julie Williams, MD, MS

June 24th 2025

Mena Mirhom, MD, FAPA, and Daanish Khorasani, MD

Why You Should Do a Media Literacy Elective in Psychiatry Residency

ByDaanish Khorasani, MD

May 16th 2025

Latest CME

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Video

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

10 Meditations on a Virtuous Career

Related Content

Striking a Balance: What Consultation-Liaison Psychiatrists Should Know About the Hospital Psychological Milieu During a Strike

On Mentoring

Spare Me the Bouquets: The Growing Crisis of Being a Doctor in India

Walking the Line: Navigating Student Mistreatment by Patients

Why You Should Do a Media Literacy Elective in Psychiatry Residency

Latest CME

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Zuranolone in the Room: Closing the Gap in Postpartum Depression Care

The Psychiatric Impact of Cannabis Policy: More Than a Legal Framework

Classic Drug, New Target: Lithium as Disease-Modifying in Alzheimer Dementia

FDA Accepts NDA for AXS-12 for the Treatment of Cataplexy in Narcolepsy

What's Next for Psychedelics in Psychiatry? COMP360 and Beyond